Vaxart, Inc. (VXRT)
NASDAQ: VXRT · IEX Real-Time Price · USD
0.675
-0.009 (-1.26%)
At close: Jul 19, 2024, 4:00 PM
0.673
-0.002 (-0.30%)
Pre-market: Jul 22, 2024, 7:27 AM EDT

Vaxart Revenue

Vaxart had revenue of $8.89M in the twelve months ending March 31, 2024, with 1,174.75% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.18M with 223.11% year-over-year growth. In the year 2023, Vaxart had annual revenue of $7.38M with 6,796.26% growth.

Revenue (ttm)
$8.89M
Revenue Growth
+1,174.75%
P/S Ratio
17.28
Revenue / Employee
$81,514
Employees
109
Market Cap
153.51M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.38M7.27M6,796.26%
Dec 31, 2022107.00K-785.00K-88.00%
Dec 31, 2021892.00K-3.15M-77.95%
Dec 31, 20204.05M-5.82M-58.97%
Dec 31, 20199.86M5.70M137.12%
Dec 31, 20184.16M-1.68M-28.77%
Dec 31, 20175.84M-3.46M-37.22%
Jun 30, 20169.30M-15.30M-62.20%
Jun 30, 201524.60M-44.10M-64.19%
Jun 30, 201468.70M35.10M104.46%
Jun 30, 201333.60M13.20M64.71%
Jun 30, 201220.40M7.90M63.20%
Jun 25, 201112.50M-22.51M-64.29%
Dec 25, 201035.01M24.52M233.73%
Dec 26, 200910.49M--
Dec 27, 20080--
Dec 29, 20070--
Dec 30, 20060--
Dec 31, 20050--
Dec 25, 2004142.18M-34.39M-19.48%
Dec 27, 2003176.57M-19.40M-9.90%
Dec 28, 2002195.97M-38.86M-16.55%
Dec 29, 2001234.83M6.05M2.64%
Dec 30, 2000228.78M-4.82M-2.06%
Dec 31, 1999233.60M-9.48M-3.90%
Dec 31, 1998243.09M14.34M6.27%
Dec 31, 1997228.74M-11.17M-4.65%
Dec 31, 1996239.91M43.98M22.45%
Dec 31, 1995195.93M31.50M19.16%
Dec 31, 1994164.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
High Tide 503.78M
Assertio Holdings 142.05M
Lifecore Biomedical 103.27M
OptiNose 74.02M
Capricor Therapeutics 27.10M
Revenue Rankings